Skip to content

IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITIS

Status
Not yet recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517314-15-00
Acronym
PI2020_843_0114
Enrollment
100
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Brief summary

Carotid intima media thickness (CIMT)

Detailed description

Aortic pulse wave velocity (aPWV) / arterial stiffness, Augmentation index (AIx), Framingham score, the 10-year atherosclerotic CV disease risk (ASCVD) indices (reflect of the cardiovascular risk) and the SCORE score, Ulcerative colitis activity score /Mayo Score, Lipids parameters (HDL, LDL, TC, TG), Arterial tension and systolic pressure index, Endothelial function / Coagulation parameters

Interventions

Sponsors

Centre Hospitalier Universitaire Amiens Picardie
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Carotid intima media thickness (CIMT)

Secondary

MeasureTime frame
Aortic pulse wave velocity (aPWV) / arterial stiffness, Augmentation index (AIx), Framingham score, the 10-year atherosclerotic CV disease risk (ASCVD) indices (reflect of the cardiovascular risk) and the SCORE score, Ulcerative colitis activity score /Mayo Score, Lipids parameters (HDL, LDL, TC, TG), Arterial tension and systolic pressure index, Endothelial function / Coagulation parameters

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026